News

GlobalData on MSN1mon
EC conditionally approves MSD’s Welireg for VHL disease and RCC
Welireg is intended for adults with VHL disease who need therapy for associated renal cell carcinoma (RCC), central nervous ...
Targeted Oncology10d
HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
pharmaphorum2d
NICE clears NHS use of MSD's Welireg for genetic disorder
Specifically, Welireg becomes an option for VHL-associated renal cell carcinoma (RCC), brain and spinal cord tumours (haemangioblastomas), or pancreatic neuroendocrine tumours (pNETs) when ...
Medscape3d
Motexafin Gadolinium for the Treatment of Metastatic Renal Cell Carcinoma: Phase II Study Results
Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...